Halo-Med, Fluoxymesterolone, 10 mg, 120 Tabs

In Stock
55.00€
Discreet package Discreet package
100% Discreet, Private & Plain Stealth Packaging Guaranteed
Secure Payment Secure Payment
100% Secure, Encrypted & Confidential Payment Processing

HALO-MED 10 mg by Bioniche Pharma contains Fluoxymesterone, a highly potent oral anabolic-androgenic agent engineered to maximize cellular nitrogen conservation and tissue accretion during hypercatabolic states. Supplied as a 120-tablet container, Bioniche Pharma HALO-MED delivers robust anabolic support alongside targeted nutritional therapy to accelerate physiological recovery without inducing rapid, overt virilization at initial therapeutic doses.

CLINICAL INDICATIONS & THERAPEUTIC USE

Indicated for short-term adjunctive therapy to counter nitrogen depletion and skeletal muscle wasting in clinical scenarios demanding rapid tissue repair and metabolic stabilization using Bioniche Pharma formulations:

  • Post-surgical convalescence and functional recovery following major operative interventions utilizing Bioniche Pharma anabolic support.
  • Comprehensive physical rehabilitation following severe physical trauma, thermal burns, or complex skeletal fractures under direct medical direction.
  • Management of involuntary tissue degradation and muscle catabolism associated with chronic infectious states or debilitating systemic illness.
  • Therapeutic intervention for cachectic wasting syndromes and severe physical weakness using Bioniche Pharma treatment protocols.
DOSAGE & ADMINISTRATION

Dosing regimens for HALO-MED by Bioniche Pharma must be individually calculated and monitored under direct physician oversight based on clinical objectives, patient tolerance, and diagnostic lab profiles. Short-term administration protocols are strongly recommended to minimize hepatic and systemic physiological strain.

CONTRAINDICATIONS & PRECAUTIONS
  • Male Oncology: Strictly contraindicated in male patients with diagnosed or suspected prostate carcinoma or male breast cancer.
  • Pregnancy & Teratogenicity: Prohibited in pregnant or nursing female patients due to high risks of female fetal masculinization and developmental toxicity.
  • Hepatotoxicity Risk: As a $17\alpha$-alkylated oral formulation, routine clinical laboratory surveillance of liver transaminases (AST/ALT) and serum lipid fractions (HDL/LDL) is mandatory throughout Bioniche Pharma HALO-MED therapy.
STORAGE & HANDLING

Store Bioniche Pharma HALO-MED in a dry, cool environment protected from direct light exposure and excess atmospheric moisture. Store securely out of the reach and sight of children.